Data emerges on maintenance therapies, developing treatments for relapsed/refractory follicular lymphoma

Survival for patients with grade 1 to 2 follicular lymphoma is now measured in decades to coincide with improvements in therapy. Radiotherapy has been the recommended strategy for patients with early stage disease, based on achievement of very long remission and possibly cure in up to half of patients with this approach.